Dr. Sue J. Rhee, M.D.
Pediatric Gastroenterology (Pediatric Transplant Hepatology Physician)
At a glance
- Medical school
- Albany Medical College of Union University (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
Licensed in California since 2005, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Albany Medical College of Union University
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Transplant Hepatology Physician primary
CA license A93038 (first issued 2005; current) -
Pediatric Gastroenterology Physician
CA license A93038 (first issued 2005; current) -
Pediatrics Physician
CA license A93038 (first issued 2005; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UCSF Medical Center San Francisco, CA
Medical groups
- University of California San Francisco (1,839 clinicians)
- UCSF Pediatrics Associates (92 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Vancomycin Hcl | 36 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $8,255 in research payments for these studies, mostly to the institutions running them.
- Registry for Participants With Short Bowel Syndrome
Takeda Pharmaceuticals U.S.A., Inc. · Active, not recruiting · NCT01990040
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.